Literature DB >> 569916

Partial amino acid sequence of HLA-A9 antigen purified with a specific xenoantiserum.

J P Allison, S Ferrone, L E Walker, M A Pellegrino, J Silver, R A Reisfeld.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 569916

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression.

Authors:  R S Fujinami; J A Nelson; L Walker; M B Oldstone
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides.

Authors:  A Chersi; M C Morganti; F Chillemi; R Houghten; C Cenciarelli
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

Review 3.  [Serologic properties of antigens HLA-A, B and C].

Authors:  C Perreault
Journal:  Can Med Assoc J       Date:  1981-03-15       Impact factor: 8.262

4.  Anti-HLA antibodies of predetermined specificity: a chemically synthesized peptide induces antibodies specific for HLA-A,B heavy chain.

Authors:  W R Church; L E Walker; R A Houghten; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  Human major histocompatibility complex class I antigens: residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site.

Authors:  L E Walker; T A Ketler; R A Houghten; G Schulz; A Chersi; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.